GSK set to face jury trials over heartburn drug Zantac - Financial Times
WEBJun 1, 2024 · GSK and other pharmaceutical groups are set to face jury trials in cases brought by more than 72,000 cancer sufferers who allege a heartburn drug caused their condition, after a judge in Delaware...
GSK shares tumble after Delaware court ruling on Zantac - Financial Times
WEBJun 3, 2024 · GSK shares dropped almost 10 per cent on Monday after a ruling from a Delaware judge left the UK drugmaker exposed to US jury trials over its allegedly carcinogenic heartburn treatment Zantac.
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to …
WEBJune 3 (Reuters) - Shares of GSK (GSK.L) dropped more than 9% on Monday, after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused...
After Delaware decision, GSK faces $2B to settle Zantac lawsuits
WEBJun 3, 2024 · The decision of a Delaware judge on Friday to allow more than 75,000 Zantac lawsuits to go forward to jury trials has left four major drugmakers—GSK, Pfizer, Sanofi and Boehringer...
GSK soothes investors by settling first Zantac cancer lawsuit due …
WEBJun 23, 2023 · GSK agreed to settle a U.S. lawsuit alleging its discontinued heartburn drug Zantac caused cancer, the British drugmaker said on Friday, preventing the first such case from going to trial...
GSK readies for pivotal ruling in Zantac cases - Financial Times
WEBApr 24, 2024 · The federal court in Florida found that plaintiffs’ scientists’ findings were based on “unreliable methodologies”, in effect dismissing almost 2,500 cases in 2022, a decision that GSK said ...
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
WEBMay 2, 2024 · U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and...
Zantac litigation - GSK
WEB12 May 2023 - Statement: Zantac (ranitidine) litigation. GSK welcomes the decision of the British Columbia Supreme Court in Dussiaume v. Sandoz Canada Inc. 2023 BCSC 795 dismissing a proposed class action on behalf of a class of ranitidine users in Canada.
Victory for drugmakers GSK and Boehringer in $640 million Zantac …
WEBMay 24, 2024 · Drugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s claim that the blockbuster heartburn drug Zantac caused her cancer, handing the companies a win in...
Next stage in GSK’s Zantac defense gets underway today
WEBJan 22, 2024 · A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients.